Benign Migratory Glossitis Associated With Antiangiogenic Drugs Used in Cancer Treatment
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- Benign migratory glossitis
研究概览
简要总结
Oral clinical descriptions related to adverse events in patients treated with those elective multi-targeted receptor tyrosine kinase inhibitors and a recombinant humanised monoclonal antibody
详细描述
Electronical medical and dental records, high-resolution digital photograph were reviewed. Demographic data, medical background, clinical and laboratory information were recorded for each individual case.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patient's charts which underwent antiangiogenic targeted drugs
排除标准
- •chemoterapy without angiogenesis inhibitors
结局指标
主要结局
Benign migratory glossitis
时间窗: From enrollment to the end of study at 7 years
erythematous erosions, with loss of filiform papillae, surrounded by white circinate rims on the dorsal tongue
次要结局
- Adverse events(From enrollment to the end of study at 7 years)
研究者
MAURICIO NEVES GOMES
Assistant, Dental Oncology Service, Instituto do Câncer do Estado de São Paulo (ICESP-FMUSP)
Instituto do Cancer do Estado de São Paulo
